SCHEMBL8310570

SCHEMBL8310570

CC(C)C(=O)NCc1cc(Cl)cc(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ERCC1 P07992 1/20 0.56
▸ ERCC4 Q92889 1/20 0.56
▸ CARM1 Q86X55 1/20 0.50
▸ PRMT6 Q96LA8 1/20 0.50
▸ TACR1 P25103 1/20 0.50
▸ LMNA P02545 2/20 0.47
▸ P2RX7 Q99572 1/20 0.44
▸ PTGES O14684 2/20 0.42
▸ WDR5 P61964 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MASP2 O00187 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18251698 0.90 ERCC1 (0.50) ERCC1ERCC4CARM1PRMT6TACR1
SCHEMBL5025058 0.84 TACR1 (0.50) ERCC1ERCC4CARM1PRMT6TACR1
SCHEMBL12864453 0.83 ERCC1 (0.58) ERCC1ERCC4LMNAALDH1A1MEN1
SCHEMBL8310068 0.81 MEN1 (0.63) ERCC1ERCC4CARM1PRMT6LMNA
SCHEMBL12452827 0.81 ERCC1 (0.56) ERCC1ERCC4CARM1PRMT6LMNA
SCHEMBL20428059 0.79 ERCC1 (0.57) ERCC1ERCC4CARM1PRMT6TACR1
SCHEMBL4068730 0.79 TACR1 (0.50) TACR1P2RX7WDR5ALDH1A1KDM4E
SCHEMBL12131750 0.78 ERCC1 (0.70) ERCC1ERCC4LMNAMEN1KMT2A
SCHEMBL8310339 0.78 ERCC1 (0.56) ERCC1ERCC4ALDH1A1L3MBTL1
SCHEMBL8310378 0.77 TSHR (0.66) ERCC1ERCC4LMNAPTGESALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217794-B2 Compounds and methods for treatment of thrombosis DAIAMED, INC. (US) 2007-05-15 — — US disclosed
US-7217794-B2 Compounds and methods for treatment of thrombosis DAIAMED, INC. (US) 2007-05-15 — — US disclosed
WO-2004089297-A2 COMPOUNDS AND METHODS FOR TREATMENT OF THROMBOSIS SUNTORY PHARMACEUTICAL RESEARCH LABORATORIES, LLC (US) 2004-10-21 — — WO disclosed
Send feedback